Study summary · research use only
Producing human mechano growth factor (MGF) in Escherichia coli
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this laboratory study (no whole animal; using Escherichia coli and human cells), the authors describe producing human mechano growth factor (MGF), a muscle-specific splice variant of the IGF1 gene with a specific 16-amino-acid E-peptide at the C-terminus. They report that recombinant MGF was expressed in E. coli as inclusion bodies (about 100-200 mg/l), then purified and refolded. Biological activity of the refolded MGF was analyzed in vitro in proliferation assays with normal human myoblasts. The authors state this allowed generation of a characterized MGF control and a ready-to-use MGF test system not previously described, and they discuss potential future applications for muscle growth, post-trauma repair, myodystrophy, and sports medicine. No efficacy claims or numerical activity values were reported in the abstract.
Abstract
MGF is a product of a unique muscle-specific splice variant of IGF1 gene (insulin-like growth factor). Its peculiar feature is a specific E-peptide, a 16 a.a. strand at the C-terminus. MGF increases cellular proliferation and inhibits terminal differentiation of myoblasts necessary for the secondary myotube formation. Previous analysis of physiological effects of MGF was performed using indirect methods such as RT-PCR based examination of the transcript contents in normal tissues, adenovirus-mediated DNA delivery and synthetic E-domain administration. Here, we describe isolation and purification of recombinant MGF thus allowing for the first time the possibility of direct examining MGF effects. The recombinant MGF of directly examining--was expressed in Escherichia coli as inclusion bodies (about 100-200mg/l), purified and refolded. Biological activity of refolded MGF was analyzed in vitro in proliferation assays with normal human myoblasts. As a result of our work, it has become possible to generate a standard MGF control with characterized activity and a ready-to use MGF test-system neither of which have been previously described. Our data open opportunities for the future works on MGF characterization and to the development of a powerful and highly specific therapeutic agent potentially applicable for muscle growth up-regulation, post-trauma muscle repair, age and hereditary myodystrophy mitigation and in sport medicine.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.